• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Diabetes Market

    ID: MRFR/Pharma/2180-HCR
    60 Pages
    Kinjoll Dey
    September 2025

    India Diabetes Market information, by Type (Type 1, Type 2, and Gestational diabetes), by Test (Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others), by Devices (Blood glucose monitoring devices, Diabetes management devices, and others) by Treatment (Medications, Insulin therapy, Transplantation, Bariatric surgery and others) - Forecast to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Diabetes Market Research Report - Forecast To 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Diabetes Market Summary

    The Global India Diabetes Market is projected to experience substantial growth from 6.86 USD Billion in 2024 to 13.9 USD Billion by 2035.

    Key Market Trends & Highlights

    India Diabetes Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 13.9 USD Billion, indicating a robust expansion.
    • In 2024, the market is valued at 6.86 USD Billion, reflecting the increasing prevalence of diabetes in India.
    • Growing adoption of digital health technologies due to rising health awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.86 (USD Billion)
    2035 Market Size 13.9 (USD Billion)
    CAGR (2025-2035) 6.6%

    Major Players

    Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc. (US), Johnson & Johnson Services, Inc. (US), Bayer AG (Germany), Ypsomed (Switzerland)

    Diabetes Market Trends

    The leading causes of diabetes mellitus in Indians are obesity, particularly central obesity, increased visceral fat brought on by physical inactivity, and diets high in calories, fat, and sugar. The most prevalent work culture that is still practised in the nation, which involves consuming fast food while engaging in little to no physical exercise and spending hours in one position while seated, is a major factor in the rapid rise in diabetes incidence among India's working-age population.

    Additionally, the rising number of diabetic people and its growing prevalence and expanding use of insulin-delivery and continuous glucose monitoring devices are propelling market expansion. In India, 77 million people were estimated to have diabetes in 2019, and by 2045, that number is expected to reach over 134 million. About 57% of these people are still undiagnosed. However, problems faced by poor individuals across India in managing diabetes care are major restraining factors for the market.

    The rising prevalence of diabetes in India underscores the urgent need for enhanced healthcare strategies and public awareness initiatives to combat this growing health crisis.

    Ministry of Health and Family Welfare, Government of India

    Diabetes Market Drivers

    Market Growth Projections

    The Global India Diabetes Market Industry is poised for substantial growth, with projections indicating a market value of 6.86 USD Billion in 2024 and an anticipated increase to 13.9 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 6.6% from 2025 to 2035, reflecting the increasing demand for diabetes management solutions. The market's expansion is likely driven by various factors, including rising diabetes prevalence, technological advancements, and supportive government initiatives. Such projections underscore the potential for investment and innovation within the diabetes sector in India.

    Rising Prevalence of Diabetes

    The Global India Diabetes Market Industry is experiencing a notable surge due to the increasing prevalence of diabetes across the nation. As of 2024, approximately 77 million individuals in India are living with diabetes, a figure that is projected to rise significantly in the coming years. This alarming trend is driven by factors such as urbanization, sedentary lifestyles, and dietary changes. The growing number of diabetic patients is likely to propel the market value to an estimated 6.86 USD Billion in 2024, with expectations of reaching 13.9 USD Billion by 2035. Such statistics indicate a pressing need for innovative solutions and healthcare interventions.

    Growing Awareness and Education

    The Global India Diabetes Market Industry is experiencing growth due to increased awareness and education regarding diabetes. Public health campaigns and educational programs are effectively informing individuals about the risks associated with diabetes and the importance of early detection and management. This heightened awareness is encouraging more people to seek medical advice and adopt healthier lifestyles, which may contribute to a decrease in diabetes-related complications. As awareness continues to grow, the market is likely to benefit from a larger patient base seeking innovative solutions, aligning with the projected CAGR of 6.6% from 2025 to 2035.

    Increasing Healthcare Expenditure

    The Global India Diabetes Market Industry is positively impacted by the rising healthcare expenditure in India. As the government and private sectors allocate more resources to healthcare, there is a growing focus on diabetes management and treatment. Increased funding allows for better access to medications, diagnostic tools, and healthcare services, which are essential for managing diabetes effectively. This trend is expected to drive the market value to 6.86 USD Billion in 2024, with a robust growth trajectory leading to 13.9 USD Billion by 2035. Enhanced healthcare spending is likely to improve patient outcomes and support the overall growth of the diabetes market.

    Government Initiatives and Policies

    The Global India Diabetes Market Industry is bolstered by various government initiatives aimed at combating diabetes. The Indian government has implemented numerous health programs focusing on diabetes awareness, prevention, and management. For instance, the National Program for Prevention and Control of Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) aims to reduce the burden of non-communicable diseases. These initiatives not only enhance public awareness but also facilitate access to healthcare services, thereby potentially increasing the market's growth rate. With a projected CAGR of 6.6% from 2025 to 2035, government support is crucial for fostering a healthier population and addressing the diabetes epidemic.

    Technological Advancements in Diabetes Management

    The Global India Diabetes Market Industry is significantly influenced by advancements in technology that enhance diabetes management. Innovations such as continuous glucose monitoring systems, insulin pumps, and mobile health applications are transforming how patients manage their condition. These technologies provide real-time data and personalized insights, leading to improved health outcomes. As the market evolves, the integration of artificial intelligence and telemedicine is likely to further revolutionize diabetes care. The growing adoption of these technologies is expected to contribute to the market's expansion, aligning with the projected growth to 13.9 USD Billion by 2035.

    Market Segment Insights

    Regional Insights

    Key Companies in the Diabetes Market market include

    Industry Developments

    February 2024:In February 2024, Roche Diabetes Care Launched a new continuous glucose monitoring (CGM) system in India, aiming to improve diabetes management and glycemic control.

    Study objectives of India Diabetes Market

      • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian Diabetes Market
      • To provide insights about factors affecting the market growth
      • To analyze the India Diabetes Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc.
      • To provide historical and forecast revenue of the market segments and sub-segments
      • To provide detailed analysis of the market with respect to the current market size and future prospective
      • To provide detailed analysis of the market for segments by type, by test, by devices, by treatment, and its sub-segments.
      • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
      • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Market

     Intended Audience

      • Hospitals and Clinics
      • Diabetes drugs and devices manufacturers
      • Diabetes drugs and devices suppliers
      • Government and Independent Regulatory Authorities
      • Research and Development (R&D) Companies
      • Market Research and Consulting Service Providers
      • Medical Research Laboratories
      • Potential Investors

    Future Outlook

    Diabetes Market Future Outlook

    The India Diabetes Market is projected to grow at a 6.6% CAGR from 2024 to 2035, driven by rising prevalence, technological advancements, and increased healthcare expenditure.

    New opportunities lie in:

    • Develop digital health solutions for diabetes management and patient engagement.
    • Invest in innovative insulin delivery systems to enhance patient compliance.
    • Expand access to affordable diabetes medications in rural areas through strategic partnerships.

    By 2035, the India Diabetes Market is expected to be robust, reflecting substantial growth and innovation.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023  USD 6.75 billion
    Market Size 2024 USD 6.86 billion
    Market Size 2032 USD 11.46 billion
      CAGR   6.54% (2024-2032)
      Base Year   2023
      Forecast Period   2024-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Test, Devices, Treatment
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland)
      Key Market Opportunities   Research and developments
      Key Market Drivers ·  Increasing number of patients·  Increasing urbanization·  Healthcare infrastructure·  Increasing spending on healthcare

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    1.     Report Prologue
    2.     Introduction
      1.     Definition
      2.     Scope of the Study
        1.     Research Objective
        2.     Assumptions
        3.     Limitations
      3.     Market Structure
      4.     Market Segmentation
    3.     Research Methodology
      1.     Research Process
      2.     Primary Research
      3.     Secondary Research
      4.     Market Size Estimation
      5.     Forecast Model
    4.     Market Dynamics
      1.     Drivers
      2.     Restraints
      3.     Opportunities
      4.     Mega Trends
      5.     Macroeconomic Indicators
    5.     Market Factor Analysis
      1.     Value Chain Analysis
      2.     Porters Five Forces
      3.     Demand & Supply: Gap Analysis
      4.     Pricing Analysis
      5.     Investment Opportunity Analysis
      6.     Merger and Acquisition Landscape
      7.     Upcoming trends
        1. Market trends
        2. Technological trends
        3. Insurance & Regulations
        4. Others
    6.     India Diabetes Market by Type
    7.     India Diabetes Market by Test    
    8.     India Diabetes Market by Devices
    9.     India Diabetes Market by Treatment
    10.     India Diabetes Market by Region
      1.     Introduction
      2.     Western region
      3.     Eastern region
      4.     Southern region
      5.     Northern region
      6.      Central region

    India Diabetes Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    India Diabetes Market Research Report - Forecast To 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials